Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Guilleminault

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Pulmonary Pharmacology & Therapeutics|March 1, 2019
Chronic cough and obesityLaurent Guilleminault
Presse Medicale (Paris, France : 1983)|March 30, 2019
[Severe asthma revisited by biologic therapies emergences]Laurent Guilleminault, Alain Didier
Archivos De Bronconeumologia|May 16, 2024
Sequential and Multimodal Bronchoscopic Interventions for COPD: Toward a Highly Personalized Interventional Pulmonology?Thomas Villeneuve, Laurent Guilleminault, Nicolas Guibert
Presse Medicale (Paris, France : 1983)|March 31, 2019
[From acute cough to chronic cough in adults: Overview on a common reason for consultation]Laurent Guilleminault, Danielle Brouquières, Alain Didier
Clinical Reviews in Allergy & Immunology|September 22, 2021
Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food AllergyLaurent Guilleminault, Marine Michelet, Laurent Lionel Reber
Pharmacology & Therapeutics|March 14, 2022
Pharmacological approaches to target type 2 cytokines in asthmaLaurent Guilleminault, Eva Conde, Laurent L Reber
The Journal of Allergy and Clinical Immunology. in Practice|October 6, 2024
Rheumatic adverse effects with biologics targeting type 2 inflammation in severe asthma: A VigiBase studyMiranda Laux, François Montastruc, Yannick Degboe, et al.
Drugs|June 21, 2024
Drugs Targeting Cough Receptors: New Therapeutic Options in Refractory or Unexplained Chronic CoughLaurent Guilleminault, Stanislas Grassin-Delyle, Stuart B Mazzone
Pediatric Pulmonology|May 31, 2024
What is the future of children and adolescents with severe asthma treated with biological therapy?Clara Ladoux, Laurent Guilleminault, Marine Michelet, et al.
Lung|March 27, 2026
Asthma Reporting with Anti-TNFα Drugs used in Inflammatory Joint Diseases: A Vigibase® Study with Disproportionality AnalysisMatthias Nocenti, François Montastruc, Yannick Degboe, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Pulmonary Pharmacology & Therapeutics|March 1, 2019
Chronic cough and obesityLaurent Guilleminault
Presse Medicale (Paris, France : 1983)|March 30, 2019
[Severe asthma revisited by biologic therapies emergences]Laurent Guilleminault, Alain Didier
Archivos De Bronconeumologia|May 16, 2024
Sequential and Multimodal Bronchoscopic Interventions for COPD: Toward a Highly Personalized Interventional Pulmonology?Thomas Villeneuve, Laurent Guilleminault, Nicolas Guibert
Presse Medicale (Paris, France : 1983)|March 31, 2019
[From acute cough to chronic cough in adults: Overview on a common reason for consultation]Laurent Guilleminault, Danielle Brouquières, Alain Didier
Clinical Reviews in Allergy & Immunology|September 22, 2021
Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food AllergyLaurent Guilleminault, Marine Michelet, Laurent Lionel Reber
Pharmacology & Therapeutics|March 14, 2022
Pharmacological approaches to target type 2 cytokines in asthmaLaurent Guilleminault, Eva Conde, Laurent L Reber
The Journal of Allergy and Clinical Immunology. in Practice|October 6, 2024
Rheumatic adverse effects with biologics targeting type 2 inflammation in severe asthma: A VigiBase studyMiranda Laux, François Montastruc, Yannick Degboe, et al.
Drugs|June 21, 2024
Drugs Targeting Cough Receptors: New Therapeutic Options in Refractory or Unexplained Chronic CoughLaurent Guilleminault, Stanislas Grassin-Delyle, Stuart B Mazzone
Pediatric Pulmonology|May 31, 2024
What is the future of children and adolescents with severe asthma treated with biological therapy?Clara Ladoux, Laurent Guilleminault, Marine Michelet, et al.
Lung|March 27, 2026
Asthma Reporting with Anti-TNFα Drugs used in Inflammatory Joint Diseases: A Vigibase® Study with Disproportionality AnalysisMatthias Nocenti, François Montastruc, Yannick Degboe, et al.
Pageof 9